CING
Cingulate Inc
NASDAQ: CING · HEALTHCARE · BIOTECHNOLOGY
$4.71
+0.64% today
Updated 2026-04-29
Market cap
$67.01M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.44
Dividend yield
—
52W range
$3 – $12
Volume
0.5M
Cingulate Inc (CING) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-450.60%
ROA
-83.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-11.55M | — | — | — |
| 2020 | $0.00 | $-7.18M | — | — | — |
| 2021 | $0.00 | $-20.74M | — | — | — |
| 2022 | $0.00 | $-17.85M | — | — | — |
| 2023 | $0.00 | $-23.53M | — | — | — |
| 2024 | $0.00 | $-15.55M | — | — | — |
| 2025 | $0.00 | $-22.45M | — | — | — |